nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—Panic disorder—Hydrochlorothiazide—nephrolithiasis	0.0705	0.113	CcSEcCtD
Sumatriptan—Feeling cold—Hydrochlorothiazide—nephrolithiasis	0.0284	0.0457	CcSEcCtD
Sumatriptan—Stiffness—Hydrochlorothiazide—nephrolithiasis	0.0214	0.0343	CcSEcCtD
Sumatriptan—Raised liver function tests—Hydrochlorothiazide—nephrolithiasis	0.0176	0.0283	CcSEcCtD
Sumatriptan—Sleep disturbance—Hydrochlorothiazide—nephrolithiasis	0.0145	0.0233	CcSEcCtD
Sumatriptan—HTR1F—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0145	0.0384	CbGpPWpGaD
Sumatriptan—Toothache—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0214	CcSEcCtD
Sumatriptan—HTR1F—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0122	0.0323	CbGpPWpGaD
Sumatriptan—Peptic ulcer—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0195	CcSEcCtD
Sumatriptan—HTR3A—Ion channel transport—CLCN5—nephrolithiasis	0.012	0.0319	CbGpPWpGaD
Sumatriptan—HTR3A—Ion channel transport—CLCN4—nephrolithiasis	0.012	0.0319	CbGpPWpGaD
Sumatriptan—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0106	0.017	CcSEcCtD
Sumatriptan—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0166	CcSEcCtD
Sumatriptan—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0166	CcSEcCtD
Sumatriptan—Stinging—Hydrochlorothiazide—nephrolithiasis	0.01	0.0161	CcSEcCtD
Sumatriptan—Numbness—Hydrochlorothiazide—nephrolithiasis	0.0098	0.0157	CcSEcCtD
Sumatriptan—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.00938	0.0151	CcSEcCtD
Sumatriptan—HTR1D—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00926	0.0246	CbGpPWpGaD
Sumatriptan—HTR1B—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00906	0.024	CbGpPWpGaD
Sumatriptan—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.00906	0.0145	CcSEcCtD
Sumatriptan—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.009	0.0144	CcSEcCtD
Sumatriptan—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.00833	0.0134	CcSEcCtD
Sumatriptan—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.00828	0.0133	CcSEcCtD
Sumatriptan—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.00823	0.0132	CcSEcCtD
Sumatriptan—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00813	0.013	CcSEcCtD
Sumatriptan—HTR1D—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00778	0.0206	CbGpPWpGaD
Sumatriptan—ABCG2—Iron uptake and transport—ATP6V0A4—nephrolithiasis	0.00777	0.0206	CbGpPWpGaD
Sumatriptan—HTR1B—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00762	0.0202	CbGpPWpGaD
Sumatriptan—HTR1A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0069	0.0183	CbGpPWpGaD
Sumatriptan—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00682	0.0109	CcSEcCtD
Sumatriptan—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.00672	0.0108	CcSEcCtD
Sumatriptan—Swelling—Hydrochlorothiazide—nephrolithiasis	0.00669	0.0107	CcSEcCtD
Sumatriptan—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00666	0.0107	CcSEcCtD
Sumatriptan—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00654	0.0105	CcSEcCtD
Sumatriptan—HTR1F—GPCRs, Other—CHRM3—nephrolithiasis	0.00643	0.0171	CbGpPWpGaD
Sumatriptan—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00623	0.00999	CcSEcCtD
Sumatriptan—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00623	0.00999	CcSEcCtD
Sumatriptan—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0062	0.00995	CcSEcCtD
Sumatriptan—HTR1F—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00616	0.0164	CbGpPWpGaD
Sumatriptan—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00607	0.00974	CcSEcCtD
Sumatriptan—DRD2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00606	0.0161	CbGpPWpGaD
Sumatriptan—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.0059	0.00947	CcSEcCtD
Sumatriptan—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00581	0.00932	CcSEcCtD
Sumatriptan—HTR1A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0058	0.0154	CbGpPWpGaD
Sumatriptan—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00545	0.00874	CcSEcCtD
Sumatriptan—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00531	0.00853	CcSEcCtD
Sumatriptan—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00522	0.00838	CcSEcCtD
Sumatriptan—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00513	0.00824	CcSEcCtD
Sumatriptan—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.0051	0.00818	CcSEcCtD
Sumatriptan—Influenza—Hydrochlorothiazide—nephrolithiasis	0.0051	0.00818	CcSEcCtD
Sumatriptan—DRD2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0051	0.0135	CbGpPWpGaD
Sumatriptan—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.005	0.00802	CcSEcCtD
Sumatriptan—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00497	0.00797	CcSEcCtD
Sumatriptan—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00477	0.00765	CcSEcCtD
Sumatriptan—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00471	0.00756	CcSEcCtD
Sumatriptan—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00465	0.00747	CcSEcCtD
Sumatriptan—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00464	0.00745	CcSEcCtD
Sumatriptan—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.0046	0.00738	CcSEcCtD
Sumatriptan—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00448	0.00719	CcSEcCtD
Sumatriptan—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00446	0.00715	CcSEcCtD
Sumatriptan—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00442	0.00709	CcSEcCtD
Sumatriptan—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00436	0.007	CcSEcCtD
Sumatriptan—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00434	0.00696	CcSEcCtD
Sumatriptan—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00429	0.00688	CcSEcCtD
Sumatriptan—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00427	0.00685	CcSEcCtD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00418	0.0111	CbGpPWpGaD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00418	0.0111	CbGpPWpGaD
Sumatriptan—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00416	0.00667	CcSEcCtD
Sumatriptan—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00406	0.00652	CcSEcCtD
Sumatriptan—SLCO1A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00405	0.0107	CbGpPWpGaD
Sumatriptan—HTR1D—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00394	0.0105	CbGpPWpGaD
Sumatriptan—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00393	0.00631	CcSEcCtD
Sumatriptan—HTR1B—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00386	0.0102	CbGpPWpGaD
Sumatriptan—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00381	0.00611	CcSEcCtD
Sumatriptan—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00379	0.00608	CcSEcCtD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00373	0.00989	CbGpPWpGaD
Sumatriptan—SLCO1A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.0037	0.00982	CbGpPWpGaD
Sumatriptan—SLCO1A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.0037	0.00982	CbGpPWpGaD
Sumatriptan—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00365	0.00585	CcSEcCtD
Sumatriptan—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00355	0.0057	CcSEcCtD
Sumatriptan—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.0035	0.00562	CcSEcCtD
Sumatriptan—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00348	0.00558	CcSEcCtD
Sumatriptan—SLCO1B1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00346	0.00918	CbGpPWpGaD
Sumatriptan—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00344	0.00552	CcSEcCtD
Sumatriptan—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00342	0.00548	CcSEcCtD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00341	0.00904	CbGpPWpGaD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00341	0.00904	CbGpPWpGaD
Sumatriptan—MAOA—Biological oxidations—SLC26A1—nephrolithiasis	0.00336	0.00893	CbGpPWpGaD
Sumatriptan—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00333	0.00534	CcSEcCtD
Sumatriptan—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.0033	0.00529	CcSEcCtD
Sumatriptan—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00328	0.00527	CcSEcCtD
Sumatriptan—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00327	0.00524	CcSEcCtD
Sumatriptan—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00325	0.00521	CcSEcCtD
Sumatriptan—Malaise—Hydrochlorothiazide—nephrolithiasis	0.0032	0.00514	CcSEcCtD
Sumatriptan—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00319	0.00512	CcSEcCtD
Sumatriptan—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00319	0.00511	CcSEcCtD
Sumatriptan—SLCO1B1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00317	0.0084	CbGpPWpGaD
Sumatriptan—SLCO1B1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00317	0.0084	CbGpPWpGaD
Sumatriptan—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00314	0.00504	CcSEcCtD
Sumatriptan—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00312	0.00501	CcSEcCtD
Sumatriptan—Cough—Hydrochlorothiazide—nephrolithiasis	0.0031	0.00498	CcSEcCtD
Sumatriptan—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00302	0.00486	CcSEcCtD
Sumatriptan—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00302	0.00486	CcSEcCtD
Sumatriptan—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00302	0.00486	CcSEcCtD
Sumatriptan—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00301	0.00484	CcSEcCtD
Sumatriptan—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00299	0.0048	CcSEcCtD
Sumatriptan—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00296	0.00475	CcSEcCtD
Sumatriptan—HTR1A—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00294	0.0078	CbGpPWpGaD
Sumatriptan—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00292	0.00469	CcSEcCtD
Sumatriptan—Oedema—Hydrochlorothiazide—nephrolithiasis	0.0029	0.00465	CcSEcCtD
Sumatriptan—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.0029	0.00465	CcSEcCtD
Sumatriptan—Shock—Hydrochlorothiazide—nephrolithiasis	0.00285	0.00458	CcSEcCtD
Sumatriptan—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00284	0.00456	CcSEcCtD
Sumatriptan—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00283	0.00454	CcSEcCtD
Sumatriptan—SLCO1A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00281	0.00744	CbGpPWpGaD
Sumatriptan—SLCO1A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00281	0.00744	CbGpPWpGaD
Sumatriptan—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.0028	0.0045	CcSEcCtD
Sumatriptan—HTR1F—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00279	0.00741	CbGpPWpGaD
Sumatriptan—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00271	0.00435	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00264	0.00424	CcSEcCtD
Sumatriptan—SLCO1A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00261	0.00692	CbGpPWpGaD
Sumatriptan—SLCO1A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00261	0.00692	CbGpPWpGaD
Sumatriptan—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.0026	0.00418	CcSEcCtD
Sumatriptan—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00259	0.00415	CcSEcCtD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00258	0.00685	CbGpPWpGaD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00258	0.00685	CbGpPWpGaD
Sumatriptan—DRD2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00258	0.00685	CbGpPWpGaD
Sumatriptan—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00258	0.00414	CcSEcCtD
Sumatriptan—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00252	0.00405	CcSEcCtD
Sumatriptan—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.0025	0.00401	CcSEcCtD
Sumatriptan—Pain—Hydrochlorothiazide—nephrolithiasis	0.00248	0.00398	CcSEcCtD
Sumatriptan—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00248	0.00398	CcSEcCtD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.0024	0.00637	CbGpPWpGaD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.0024	0.00637	CbGpPWpGaD
Sumatriptan—SLCO1B1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.0024	0.00637	CbGpPWpGaD
Sumatriptan—SLCO1B1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.0024	0.00637	CbGpPWpGaD
Sumatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00239	0.00635	CbGpPWpGaD
Sumatriptan—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00239	0.00384	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00237	0.00381	CcSEcCtD
Sumatriptan—SLCO1A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00233	0.00617	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00231	0.00612	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00231	0.00612	CbGpPWpGaD
Sumatriptan—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.0023	0.0037	CcSEcCtD
Sumatriptan—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00229	0.00368	CcSEcCtD
Sumatriptan—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00229	0.00368	CcSEcCtD
Sumatriptan—SLCO1B1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00223	0.00592	CbGpPWpGaD
Sumatriptan—SLCO1B1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00223	0.00592	CbGpPWpGaD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00214	0.00568	CbGpPWpGaD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00214	0.00568	CbGpPWpGaD
Sumatriptan—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00214	0.00343	CcSEcCtD
Sumatriptan—HTR1F—GPCR downstream signaling—RGS14—nephrolithiasis	0.00211	0.00559	CbGpPWpGaD
Sumatriptan—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00208	0.00334	CcSEcCtD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00206	0.00546	CbGpPWpGaD
Sumatriptan—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00205	0.00329	CcSEcCtD
Sumatriptan—SLCO1B1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00199	0.00528	CbGpPWpGaD
Sumatriptan—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00198	0.00318	CcSEcCtD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00197	0.00524	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00197	0.00524	CbGpPWpGaD
Sumatriptan—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00192	0.00308	CcSEcCtD
Sumatriptan—HTR1F—Signaling by GPCR—RGS14—nephrolithiasis	0.00192	0.00508	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00188	0.00499	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00188	0.00499	CbGpPWpGaD
Sumatriptan—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00184	0.00296	CcSEcCtD
Sumatriptan—Rash—Hydrochlorothiazide—nephrolithiasis	0.00183	0.00293	CcSEcCtD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00183	0.00485	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00183	0.00485	CbGpPWpGaD
Sumatriptan—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00183	0.00293	CcSEcCtD
Sumatriptan—HTR1F—GPCR ligand binding—CHRM3—nephrolithiasis	0.00182	0.00483	CbGpPWpGaD
Sumatriptan—Headache—Hydrochlorothiazide—nephrolithiasis	0.00182	0.00292	CcSEcCtD
Sumatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00179	0.00474	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00176	0.00467	CbGpPWpGaD
Sumatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00175	0.00464	CbGpPWpGaD
Sumatriptan—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00172	0.00276	CcSEcCtD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00171	0.00454	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR ligand binding—PTH—nephrolithiasis	0.00167	0.00442	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00163	0.00432	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00161	0.00427	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00161	0.00427	CbGpPWpGaD
Sumatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00153	0.00406	CbGpPWpGaD
Sumatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.0015	0.00398	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00149	0.00395	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00149	0.00395	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00143	0.00378	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00143	0.00378	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—DGKH—nephrolithiasis	0.00142	0.00378	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—RGS14—nephrolithiasis	0.00135	0.00358	CbGpPWpGaD
Sumatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00133	0.00353	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—ADCY10—nephrolithiasis	0.00133	0.00353	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00133	0.00352	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00133	0.00352	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—RGS14—nephrolithiasis	0.00132	0.0035	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—DGKH—nephrolithiasis	0.00129	0.00343	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—RGS14—nephrolithiasis	0.00122	0.00325	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00122	0.00324	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00122	0.00324	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—RGS14—nephrolithiasis	0.0012	0.00318	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00118	0.00313	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00118	0.00313	CbGpPWpGaD
Sumatriptan—DRD2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00117	0.0031	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—CHRM3—nephrolithiasis	0.00117	0.00309	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00114	0.00303	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—CHRM3—nephrolithiasis	0.00114	0.00303	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00113	0.00301	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00113	0.00301	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—RGS14—nephrolithiasis	0.00113	0.003	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00113	0.003	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00113	0.003	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—PTH—nephrolithiasis	0.00107	0.00283	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00105	0.00278	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00105	0.00278	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—PTH—nephrolithiasis	0.00104	0.00277	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00103	0.00273	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00101	0.00268	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00101	0.00268	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.00101	0.00267	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.001	0.00266	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000988	0.00262	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000988	0.00262	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000945	0.00251	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—PTH—nephrolithiasis	0.000942	0.0025	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000936	0.00248	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000936	0.00248	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—CHRM3—nephrolithiasis	0.000935	0.00248	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—RGS14—nephrolithiasis	0.000914	0.00242	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—DGKH—nephrolithiasis	0.000911	0.00242	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—DGKH—nephrolithiasis	0.000892	0.00237	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—RGS14—nephrolithiasis	0.000883	0.00234	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000881	0.00234	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000869	0.00231	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—PTH—nephrolithiasis	0.000855	0.00227	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ADCY10—nephrolithiasis	0.000851	0.00226	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ADCY10—nephrolithiasis	0.000833	0.00221	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—DGKH—nephrolithiasis	0.000827	0.00219	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GRHPR—nephrolithiasis	0.000819	0.00217	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—DGKH—nephrolithiasis	0.00081	0.00215	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000808	0.00214	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000806	0.00214	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000806	0.00214	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—RGS14—nephrolithiasis	0.000802	0.00213	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—PTH—nephrolithiasis	0.000795	0.00211	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—DGKH—nephrolithiasis	0.000764	0.00203	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000764	0.00203	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—CHRM3—nephrolithiasis	0.000763	0.00202	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GRHPR—nephrolithiasis	0.000759	0.00201	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000748	0.00198	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—AGXT—nephrolithiasis	0.00073	0.00194	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RGS14—nephrolithiasis	0.000724	0.00192	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RGS14—nephrolithiasis	0.000708	0.00188	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GRHPR—nephrolithiasis	0.000701	0.00186	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—PTH—nephrolithiasis	0.000698	0.00185	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00068	0.0018	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—AGXT—nephrolithiasis	0.000677	0.0018	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000659	0.00175	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GRHPR—nephrolithiasis	0.000649	0.00172	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000645	0.00171	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ADCY10—nephrolithiasis	0.000635	0.00168	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—AGXT—nephrolithiasis	0.000625	0.00166	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—APRT—nephrolithiasis	0.000621	0.00165	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—SLC26A1—nephrolithiasis	0.000621	0.00165	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—DGKH—nephrolithiasis	0.000617	0.00164	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000611	0.00162	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000611	0.00162	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—PTH—nephrolithiasis	0.000602	0.0016	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—CHRM3—nephrolithiasis	0.000598	0.00159	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000597	0.00158	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—PTH—nephrolithiasis	0.00059	0.00156	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—CHRM3—nephrolithiasis	0.000586	0.00155	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—AGXT—nephrolithiasis	0.000578	0.00153	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—APRT—nephrolithiasis	0.000575	0.00153	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—SLC26A1—nephrolithiasis	0.000575	0.00153	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000568	0.00151	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000568	0.00151	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ADCY10—nephrolithiasis	0.000557	0.00148	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CHRM3—nephrolithiasis	0.000553	0.00147	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—PTH—nephrolithiasis	0.000547	0.00145	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—DGKH—nephrolithiasis	0.000542	0.00144	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RGS14—nephrolithiasis	0.00054	0.00143	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—PTH—nephrolithiasis	0.000536	0.00142	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—SLC26A1—nephrolithiasis	0.000531	0.00141	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—APRT—nephrolithiasis	0.000531	0.00141	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000506	0.00134	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000506	0.00134	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PTH—nephrolithiasis	0.000505	0.00134	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—APRT—nephrolithiasis	0.000492	0.0013	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—SLC26A1—nephrolithiasis	0.000492	0.0013	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000491	0.0013	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—DGKH—nephrolithiasis	0.000489	0.0013	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000489	0.0013	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000479	0.00127	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—DGKH—nephrolithiasis	0.000479	0.00127	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RGS14—nephrolithiasis	0.000474	0.00126	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—PTH—nephrolithiasis	0.000449	0.00119	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000446	0.00118	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—AQP1—nephrolithiasis	0.000442	0.00117	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000431	0.00114	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—AQP1—nephrolithiasis	0.00041	0.00109	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PTH—nephrolithiasis	0.000408	0.00108	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000404	0.00107	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CHRM3—nephrolithiasis	0.0004	0.00106	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PTH—nephrolithiasis	0.000395	0.00105	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CHRM3—nephrolithiasis	0.000392	0.00104	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—AQP1—nephrolithiasis	0.000378	0.001	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CHRM3—nephrolithiasis	0.000371	0.000984	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000365	0.000967	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—DGKH—nephrolithiasis	0.000365	0.000967	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PTH—nephrolithiasis	0.000358	0.00095	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CHRM3—nephrolithiasis	0.000353	0.000937	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.000351	0.000931	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—AQP1—nephrolithiasis	0.00035	0.000929	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CHRM3—nephrolithiasis	0.000346	0.000918	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CHRM3—nephrolithiasis	0.000342	0.000908	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PTH—nephrolithiasis	0.000323	0.000857	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00032	0.000849	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—DGKH—nephrolithiasis	0.00032	0.000849	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CHRM3—nephrolithiasis	0.000317	0.000841	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PTH—nephrolithiasis	0.000316	0.000839	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000313	0.000829	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—APRT—nephrolithiasis	0.000266	0.000705	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000266	0.000705	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CHRM3—nephrolithiasis	0.000264	0.000699	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—SPP1—nephrolithiasis	0.000254	0.000673	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PTH—nephrolithiasis	0.000241	0.000639	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CHRM3—nephrolithiasis	0.000231	0.000614	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PTH—nephrolithiasis	0.000212	0.000561	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—AQP1—nephrolithiasis	0.000189	0.000502	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CHRM3—nephrolithiasis	0.000171	0.000454	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SPP1—nephrolithiasis	0.000162	0.00043	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SPP1—nephrolithiasis	0.000159	0.000421	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SPP1—nephrolithiasis	0.000121	0.000321	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SPP1—nephrolithiasis	0.000106	0.000282	CbGpPWpGaD
